Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS (Q59152682)

6

Milton C. Weinstein

0 references

Sue Goldie

2

Sue J. Goldie

0 references

Kenneth A. Freedberg

3

Kenneth A. Freedberg

0 references

Bruce R Schackman

1

Bruce R. Schackman

0 references

author name string

John Brazier

https://api.crossref.org/works/10.1177%2F0272989X0202200103

5

0 references

publication date

February 2002

0 references

published in

Medical Decision Making

0 references

volume

22

0 references

issue

1

0 references

page(s)

27-38

0 references

1 reference

Whose utilities for decision analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Health values of the seriously ill. SUPPORT investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

21 January 2018

Describing Health States

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Are methods for estimating QALYs in cost-effectiveness analyses improving?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Associations between health status and utilities implications for policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. Spanish MOS-HIV and MQOL-HIV Validation Group. Medical Outcomes Study HIV Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Deriving a preference-based single index from the UK SF-36 Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Personal willingness to pay for prevention: evaluating the consequences of accidents as a basis for preventive measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

The cost-effectiveness of preventing AIDS-related opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

The cost effectiveness of combination antiretroviral therapy for HIV disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Adverse effects of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

The effect of search procedures on utility elicitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0202200103